Hepatic Steatosis Index Is Associated with Type I Diabetes Complications

被引:17
|
作者
Tripolino, Cesare [1 ]
Irace, Concetta [2 ]
Cutruzzola, Antonio [2 ]
Parise, Martina [1 ]
Barone, Milena [1 ]
Scicchitano, Caterina [1 ]
Cortese, Claudio [3 ]
Gnasso, Agostino [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, Metab Dis Unit, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[3] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2019年 / 12卷
关键词
fatty liver; type; 1; diabetes; diabetes complications; FATTY LIVER-DISEASE; ADULT PATIENTS; PREVALENCE;
D O I
10.2147/DMSO.S221969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and microvascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
引用
收藏
页码:2405 / 2410
页数:6
相关论文
共 50 条
  • [31] Knowledge, Perceptions and Concerns of Diabetes-Associated Complications among Individuals Living with Type 1 and Type 2 Diabetes Mellitus
    Sanz-Nogues, Clara
    Mustafa, Mohamad
    Burke, Helen
    O'Brien, Timothy
    Coleman, Cynthia M.
    HEALTHCARE, 2020, 8 (01)
  • [32] Effect of The Atherogenic Index of Plasma on Microvascular Complications Associated with Type 2 Diabetes Mellitus
    Atalay, Hande
    Boyuk, Banu
    Degirmencioglu, Serife
    Guzel, Savas
    Celebi, Aslan
    Ekizoglu, Ismail
    ISTANBUL MEDICAL JOURNAL, 2015, 16 (03): : 111 - 115
  • [33] Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes
    Kjeldsen, Sasha A. S.
    Thomsen, Mads N.
    Skytte, Mads J.
    Samkani, Amirsalar
    Richter, Michael M.
    Frystyk, Jan
    Magkos, Faidon
    Hansen, Elizaveta
    Thomsen, Henrik S.
    Holst, Jens J.
    Madsbad, Sten
    Haugaard, Steen B.
    Krarup, Thure
    Albrechtsen, Nicolai J. Wewer
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (11)
  • [34] Factors early in life associated with hepatic steatosis
    Quek, Sabrina Xin Zi
    Tan, Eunice Xiang-Xuan
    Ren, Yi Ping
    Muthiah, Mark
    Loo, Evelyn Xiu Ling
    Tham, Elizabeth Huiwen
    Siah, Kewin Tien Ho
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1235 - 1247
  • [35] Biomarkers of Inflammation in Patients with Type 2 Diabets Mellitus and Hepatic Steatosis
    Gavril, Radu Sebastian
    Mitu, Florin
    Leon, Maria Magdalena
    Mihalache, Laura
    Arhire, Lidia Iuliana
    Grosu, Cristina
    Gherasim, Andreea
    Nita, Otilia
    Ungureanu, Irina Oana
    Oprescu, Andrei Catalin
    Graur, Mariana
    REVISTA DE CHIMIE, 2016, 67 (09): : 1828 - 1831
  • [36] An increased skin microvessel density is associated with neurovascular complications in type 1 diabetes mellitus
    Adamska, Anna
    Pilacinski, Stanislaw
    Zozulinska-Ziolkiewicz, Dorota
    Gandecka, Agnieszka
    Grzelka, Agata
    Konwerska, Aneta
    Malinska, Agnieszka
    Nowicki, Michal
    Araszkiewicz, Aleksandra
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (06): : 513 - 522
  • [37] Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature
    Valentine, William J.
    Norrbacka, Kirsi
    Boye, Kristina S.
    ADVANCES IN THERAPY, 2024, 41 (07) : 2655 - 2681
  • [38] Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications
    Sui, Jing
    He, Mingqian
    Wang, Yue
    Zhao, Xinrui
    He, Yizhi
    Shi, Bingyin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3603 - 3614
  • [39] Prevalence of type 2 diabetes-associated complications in Pakistan
    Zia, Asima
    Bhatti, Attya
    Jalil, Fazal
    Wang, Xingbin
    John, Peter
    Kiani, Aysha Karim
    Zafar, Jamal
    Kamboh, M. Ilyas
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2016, 36 (02) : 179 - 188
  • [40] Adiponectin as a Marker of Complications in Type I Diabetes
    Habeeb, Nevin Mohamed Mamdouh
    Youssef, Omneya Ibrahim
    Saab, Azza Abdel Rahman
    El Hadidi, Eman Saleh
    INDIAN PEDIATRICS, 2012, 49 (04) : 277 - 280